AI In Revenue Cycle Management Market Size, Share, and Trends 2025 to 2034

AI In Revenue Cycle Management Market (By Type: Integrated, Standalone; By Component: Hardware, Software, Services; By Deployment Mode: Cloud, On-premises; By Application: Patient Scheduling, Eligibility and Benefits Verification, Patient Payment/Timing Estimation, Prior Authorization, Pre-billing Audits, Denials Management, Compliance Monitoring, Fraud Detection, Others; By End User: Hospitals, Physicians, Diagnostics Laboratories, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : October 2025  |  Report Code : 3305  |  Category : ICT  |  Format : PDF / PPT / Excel
Get a Sample     Report Description

List of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on AI in Revenue Cycle Management Market 

5.1. COVID-19 Landscape: AI in Revenue Cycle Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global AI in Revenue Cycle Management Market, By Type

8.1. AI in Revenue Cycle Management Market, by Type

8.1.1. Integrated

8.1.1.1. Market Revenue and Forecast

8.1.2. Standalone

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global AI in Revenue Cycle Management Market, By Component

9.1. AI in Revenue Cycle Management Market, by Component

9.1.1. Hardware

9.1.1.1. Market Revenue and Forecast

9.1.2. Software

9.1.2.1. Market Revenue and Forecast

9.1.3. Services

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global AI in Revenue Cycle Management Market, By Deployment Mode 

10.1. AI in Revenue Cycle Management Market, by Deployment Mode

10.1.1. Cloud

10.1.1.1. Market Revenue and Forecast

10.1.2. On-premises

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global AI in Revenue Cycle Management Market, By Application

11.1. AI in Revenue Cycle Management Market, by Application

11.1.1. Patient Scheduling

11.1.1.1. Market Revenue and Forecast

11.1.2. Eligibility and Benefits Verification

11.1.2.1. Market Revenue and Forecast

11.1.3. Patient Payment/Timing Estimation

11.1.3.1. Market Revenue and Forecast

11.1.4. Prior Authorization

11.1.4.1. Market Revenue and Forecast

11.1.5. Pre-billing Audits

11.1.5.1. Market Revenue and Forecast

11.1.6. Denials Management

11.1.6.1. Market Revenue and Forecast 

11.1.7. Compliance Monitoring

11.1.7.1. Market Revenue and Forecast

11.1.8. Fraud Detection

11.1.8.1. Market Revenue and Forecast

11.1.9. Others

11.1.9.1. Market Revenue and Forecast

Chapter 12. Global AI in Revenue Cycle Management Market, By End User

12.1. AI in Revenue Cycle Management Market, by End User

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast

12.1.2. Physicians

12.1.2.1. Market Revenue and Forecast

12.1.3. Diagnostics Laboratories

12.1.3.1. Market Revenue and Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global AI in Revenue Cycle Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Forecast, by End User (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Forecast, by End User (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.7.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.7.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.4. Market Revenue and Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Forecast, by End User (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.7. Market Revenue and Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Forecast, by End User (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.10. Market Revenue and Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Forecast, by End User (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Forecast, by End User (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Forecast, by End User (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Forecast, by End User (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Forecast, by End User (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Forecast, by End User (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Forecast, by End User (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Forecast, by End User (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Forecast, by End User (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)

Chapter 14. Company Profiles

14.1. Oracle Cerner

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Epic Systems Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. GeBBS Healthcare Solutions

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. eClinicalWorks

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. GE Healthcare

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Mckesson Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Veradigm LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Athenahealth, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Experian Information Solutions, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Quest Diagnostics Incorporated

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players operating in the AI in revenue cycle management market are Oracle Cerner, Epic Systems Corporation, GeBBS Healthcare Solutions, eClinicalWorks, GE Healthcare, Mckesson Corporation, Veradigm LLC, Athenahealth, Inc., Experian Information Solutions, Inc., Quest Diagnostics Incorporated, and Others.

The driving factors of the AI in revenue cycle management market are the increased staff productivity and rising healthcare costs and the need for healthcare providers to improve their financial performance.

North America region will lead the global AI in revenue cycle management market during the forecast period 2025 to 2034.
Share With: LinkedIn Twitter Facebook Email Reddit

Select User License to Buy

USD 4900  USD 3900
USD 3800  USD 3200
USD 2700  USD 2100
USD 2700  USD 2100
USD 7400  USD 5900
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample

Connect with us now; your solution awaits on the other side!

Contact Us